Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Other Operating Expenses (2017 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Other Operating Expenses for 9 consecutive years, with $75.2 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to $75.2 million, compared with a TTM value of $75.2 million through Dec 2025, up 7521800.0%, and an annual FY2025 reading of $75.2 million, changed N/A over the prior year.
  • Other Operating Expenses was $75.2 million for Q1 2025 at Tandem Diabetes Care, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $78.8 million in Q1 2023 and bottomed at -$1000.0 in Q4 2024.
  • Average Other Operating Expenses over 4 years is $37.0 million, with a median of $31.0 million recorded in 2022.